Mercaptopurine 20mg/ml oral suspension
BNF presentation 0801030L0AAAQAQ within chapter Malignant Disease and Immunosuppression. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
0801030L0AAAQAQ
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
135
NHS spend (£)
£22,532.01
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 20 |
| December 2024 | 6 |
| November 2024 | 15 |
| October 2024 | 18 |
| July 2024 | 21 |
| May 2024 | 2 |
| July 2021 | 13 |
| June 2021 | 6 |
| December 2020 | 18 |
| November 2020 | 16 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 4 | No data available |
|
Granta Medical Practices
ODS D81043
|
4 | 06H - CAMBRIDGESHIRE & PETERBOROUGH ICB |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
|
Westrop Medical Practice
ODS J83002
|
4 | 92G - BATH&NE SOMERSET,SWINDON&WILTS ICB |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |